Getinge AB (publ) (GETI-B.ST)
- Previous Close
229.20 - Open
230.70 - Bid 235.30 x --
- Ask 235.40 x --
- Day's Range
230.20 - 236.60 - 52 Week Range
174.20 - 268.80 - Volume
640,684 - Avg. Volume
841,361 - Market Cap (intraday)
64.034B - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
28.02 - EPS (TTM)
8.39 - Earnings Date Jul 18, 2024
- Forward Dividend & Yield 4.40 (1.92%)
- Ex-Dividend Date Apr 23, 2024
- 1y Target Est
260.56
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
www.getinge.comRecent News: GETI-B.ST
Performance Overview: GETI-B.ST
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GETI-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GETI-B.ST
Valuation Measures
Market Cap
62.43B
Enterprise Value
67.40B
Trailing P/E
27.29
Forward P/E
22.27
PEG Ratio (5yr expected)
2.63
Price/Sales (ttm)
1.94
Price/Book (mrq)
1.93
Enterprise Value/Revenue
2.09
Enterprise Value/EBITDA
11.66
Financial Highlights
Profitability and Income Statement
Profit Margin
7.10%
Return on Assets (ttm)
4.15%
Return on Equity (ttm)
7.22%
Revenue (ttm)
32.2B
Net Income Avi to Common (ttm)
2.28B
Diluted EPS (ttm)
8.39
Balance Sheet and Cash Flow
Total Cash (mrq)
3.36B
Total Debt/Equity (mrq)
25.55%
Levered Free Cash Flow (ttm)
2.49B
Research Analysis: GETI-B.ST
Company Insights: GETI-B.ST
GETI-B.ST does not have Company Insights